Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study

A pandemic designated as Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker for the timely prediction of the disease progression in patients. To analyze the inflammatory profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yalan, Liu, Tao, Shao, Liang, Li, Xinyi, He, Colin K., Jamal, Muhammad, Luo, Yi, Wang, Yingying, Liu, Yanan, Shang, Yufeng, Pan, Yunbao, Wang, Xinghuan, Zhou, Fuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671095/
https://www.ncbi.nlm.nih.gov/pubmed/33172355
http://dx.doi.org/10.1080/21505594.2020.1840108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671095/
https://www.ncbi.nlm.nih.gov/pubmed/33172355
http://dx.doi.org/10.1080/21505594.2020.1840108

Ejemplares similares